Jpmorgan Chase & CO Corcept Therapeutics Inc Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 253,070 shares of CORT stock, worth $14.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

253,070

Previous 176,497 43.38%

Holding current value

$14.2 Million

Previous $5.73 Million 104.17%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$29.51 - $46.26 $2.26 Million - $3.54 Million	76,573 Added 43.38%	253,070 $11.7 Million
Q2 2024 Aug 12, 2024	SELL	$22.21 - $34.48 $379,213 - $588,711	-17,074 Reduced 8.82%	176,497 $5.73 Million
Q1 2024 May 10, 2024	SELL	$21.1 - $27.46 $126,874 - $165,116	-6,013 Reduced 3.01%	193,571 $4.88 Million
Q4 2023 Feb 12, 2024	BUY	$24.82 - $32.88 $173,740 - $230,160	7,000 Added 3.63%	199,584 $6.48 Million
Q3 2023 Nov 14, 2023	SELL	$21.97 - $33.8 $657,386 - $1.01 Million	-29,922 Reduced 13.45%	192,584 $5.25 Million
Q2 2023 Aug 11, 2023	SELL	$21.44 - $25.15 $1.46 Million - $1.71 Million	-68,086 Reduced 23.43%	222,506 $4.95 Million
Q1 2023 May 18, 2023	BUY	$19.2 - $24.47 $2.17 Million - $2.77 Million	113,105 Added 63.73%	290,592 $6.29 Million
Q1 2023 May 11, 2023	SELL	$19.2 - $24.47 $1.25 Million - $1.59 Million	-64,959 Reduced 26.79%	177,487 $3.84 Million
Q4 2022 Feb 13, 2023	BUY	$19.95 - $29.96 $208,178 - $312,632	10,435 Added 4.5%	242,446 $4.92 Million
Q3 2022 Nov 14, 2022	BUY	$24.7 - $29.12 $81,411 - $95,979	3,296 Added 1.44%	232,011 $5.95 Million
Q2 2022 Aug 11, 2022	BUY	$17.33 - $25.3 $218,947 - $319,640	12,634 Added 5.85%	228,715 $5.44 Million
Q1 2022 May 11, 2022	BUY	$16.53 - $25.21 $83,245 - $126,957	5,036 Added 2.39%	216,081 $4.87 Million
Q4 2021 Feb 10, 2022	SELL	$17.1 - $23.34 $5.36 Million - $7.32 Million	-313,577 Reduced 59.77%	211,045 $4.18 Million
Q3 2021 Nov 12, 2021	BUY	$19.68 - $22.53 $10.3 Million - $11.8 Million	524,622 New	524,622 $10.3 Million

Others Institutions Holding CORT

# of Institutions

347

Shares Held

86.6M

Call Options Held

1.12M

Put Options Held

667K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.01B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Corcept Therapeutics Inc Transaction History